Given that teicoplanin therapy, compared with vancomycin, showed a trend toward higher mortality and a shorter time to AAT in the univariable analysis, underdosing of teicoplanin could have attenuated the benefit of early AAT.
← all excerpts
Time to initial glycopeptide therapy and 30-day mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.
1
—
—